Omnia SanaPlant Comparison
Garlic vs Purple coneflower
A side-by-side comparison of two medicinal plants — every documented constituent, action, use, safety note and cited source, assembled automatically from the Omnia Sana database.
At a glance
Garlic and Purple coneflower: they share 7 indicated uses (arthritis / joint pain, cold & flu, immune support, …); 3 pharmacological actions in common.
Evidence face-off — shared uses
| Condition | Garlic | Purple coneflower | Verdict |
|---|---|---|---|
| Arthritis / joint pain | 9/10 | 1/10 | Stronger for Garlic |
| Cold & flu | 9/10 | 1/10 | Stronger for Garlic |
| Immune support | 9/10 | 1/10 | Stronger for Garlic |
| Infection (general) | 8/10 | 1/10 | Stronger for Garlic |
| Inflammation (general) | 9/10 | 1/10 | Stronger for Garlic |
| Skin irritation | 9/10 | 1/10 | Stronger for Garlic |
| Wounds | 8/10 | 1/10 | Stronger for Garlic |
Evidence scores (1–10) are computed from the tier of each cited source. “Comparable” means the two scores are within one point. Follow a score to its detailed sources.
Key Constituents
Allicin (diallyl thiosulfinate), formed enzymatically when raw garlic is crushed, together with ajoene and the aged-garlic compound S-allyl-cysteine, are the principal bioactives behind garlic's antimicrobial and cardiovascular effects — acting partly by raising nitric oxide and by targeting microbial thiol-containing enzymes.
Lipophilic alkamides are considered key immunomodulatory and anti-inflammatory constituents, particularly concentrated in the root.
Antioxidant phenolic compounds contributing to the plant's immunomodulatory activity.
Water-soluble polysaccharides associated with immune-stimulating activity, particularly from the aerial parts.
Pharmacological Actions
Garlic organosulfur compounds (allicin, diallyl trisulfide, ajoene, S-allylcysteine) induce apoptosis and cell-cycle arrest and inhibit proliferation, invasion and metastasis across leukaemia, breast, colon and other cancers (preclinical); a randomized trial found garlic supplementation reduced gastric-cancer mortality.
Traditional & Indicated Uses
inferred from anti-inflammatory action
inferred from antidiabetic action
Garlic and its organosulfur compounds show broad preclinical anticancer/chemopreventive activity (apoptosis, cell-cycle arrest, anti-invasion); in the randomized Shandong Intervention Trial, 7 years of garlic supplementation significantly reduced gastric-cancer mortality over 22-year follow-up (preclinical + RCT).
inferred from immunomodulator action
inferred from antifungal action
inferred from anti-inflammatory action
inferred from antidiabetic action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
inferred from immunomodulator action
inferred from antimicrobial action
inferred from anti-inflammatory action
inferred from anti-inflammatory action
Safety, Cautions & Contraindications
Garlic is generally very safe at culinary and supplemental doses for most healthy adults. Raw garlic contains allicin (formed when crushed) at concentrations that can irritate the gastrointestinal tract — nausea, heartburn, flatulence, and diarrhoea are the most common side effects, especially with large amounts of raw garlic on an empty stomach. Garlic may inhibit platelet aggregation and enhance anticoagulant effects of warfarin — use caution with blood-thinning medications, especially before surgery (stop 7–10 days prior). May lower blood pressure and blood sugar — caution when combined with antihypertensive or antidiabetic medications. Topical raw garlic can cause chemical burns (contact dermatitis) and should not be applied undiluted to skin for prolonged periods. Odour (from allicin metabolites) affects breath and perspiration. Pregnancy: culinary amounts safe; avoid medicinal-dose supplements due to blood-thinning risk (National Center for Complementary and Integrative Health, 2021).
Duke (2002) rates garlic as +++ with exceptional clinical evidence (score 3) for antiseptic activity, and score 2 for anti-aggregant (antiplatelet), antiatherosclerotic, antiatherogenic, antibacterial, and antimycotic effects — among the most clinically validated herbal medicines. Commission E approves garlic for arteriosclerosis prevention and elevated blood lipids. Dose: 4 g (1 clove) fresh garlic daily, or 300 mg standardized dry powder extract (1.3% allicin) three times daily. Important interaction: garlic significantly potentiates anticoagulant medications (warfarin, aspirin) due to its anti-aggregant effects; use with caution in patients on blood thinners (Duke, 2002).
Generally considered safe, but caution advised for those with autoimmune conditions. Not recommended for long-term use (more than 8 weeks continuously).
Duke (2002) rates echinacea as +++ — among the most thoroughly documented herbal immunostimulants. It notes experimental and clinical evidence for immunostimulant, antiviral, and anti-inflammatory activities. Multiple species have been studied (E. purpurea, E. angustifolia, E. pallida), and Duke emphasizes that species identification in commercial products is often unreliable. Commission E approves E. purpurea for supporting immune function during colds and flu. Dose: 900 mg standardized extract daily in acute use; use should be limited to 8 weeks continuous. Contraindicated in autoimmune diseases (MS, lupus, HIV/AIDS), tuberculosis, and with immunosuppressive drugs (cyclosporine) (Duke, 2002).
External Ids
Botanical Description
Bulbous perennial herb usually grown as an annual, forming an underground compound bulb ('head') of several angular cloves wrapped in papery white to purplish skin. The leaves are flat, narrow and strap-shaped, greyish-green, arising from the bulb. A tall, leafless flowering stem (scape) may rise from the bulb bearing a rounded umbel of small pink-white flowers, often mixed with small bulbils, though cultivated garlic rarely sets true seed.[1]
Robust perennial herb with a basal rosette of coarse, hairy, lance-shaped leaves and tall, sturdy flowering stems. Each stem bears a single large, daisy-like flower head with drooping (reflexed), rose-purple to pink ray florets surrounding a prominent, spiny, orange-brown central cone of disc florets.[4]
Habitat
Believed to originate in Central Asia; cultivated worldwide in temperate and subtropical climates as a garden and field crop, thriving in well-drained, sunny sites.[1]
Native to the tallgrass prairies, open woodland and dry meadows of central and eastern North America; widely cultivated worldwide as a garden and medicinal plant.[4]
Harvesting
Bulbs are lifted in mid- to late summer once the leaves have yellowed and died back, then cured (dried) in a warm, airy place before storage; young leaves and immature flower scapes ('sprouts') can be cut earlier in the season.
The flower heads are picked as they open, in summer; the root is dug in autumn from plants at least two to three years old, when its content of bioactive alkamides and caffeic acid derivatives is highest, then cleaned and dried.[4]
Traditional Uses
Garlic has one of the longest continuous medicinal histories of any plant, used across many traditional systems (Ayurvedic, Chinese, Egyptian, Greco-Roman and European folk medicine) as an antimicrobial, cardiovascular and respiratory remedy, for colds and infections, and as a digestive and immune tonic. This traditional reputation is now among the most extensively clinically studied of all herbal medicines.[1, 9]
Echinacea root was widely used by Native American peoples as a remedy for infections, wounds, snakebite and toothache, and entered nineteenth-century Eclectic medicine as a broad anti-infective. It remains best known today, in standardised aerial-part or root extracts, as a supportive remedy for preventing and shortening the common cold and supporting immune function.[1, 4]
Preparations
Fresh-pressed juice or standardised extract of the aerial parts or root, taken as tablets, drops or capsules at the first sign of a cold; the best-studied clinical form.
Dosage
The WHO monograph on Bulbus Allii Sativi gives an average daily dose of 2-5 g of fresh garlic (roughly one to two cloves), alongside 0.4-1.2 g of dried powder, 2-5 mg of oil and 300-1000 mg of extract as solid material. The EU herbal monograph gives no posology for fresh cloves, so WHO is the source here. Educational reference only, not a prescription.
The EU herbal monograph gives, for adults and elderly, powdered herbal substance at a single dose of 300-750 mg for a daily dose of 900-1380 mg divided into 3 to 5 doses; liquid extract 110-220 mg four times daily; and, for the second indication, dry extract 100-200 mg 1-2 times daily (daily dose 100-400 mg). Garlic is CONTRAINDICATED in patients on saquinavir/ritonavir therapy. Not recommended under 18 years for the first indication. Educational reference only, not a prescription.
Clinical trials for the common cold commonly use around 300-900 mg of standardised extract daily, started at the first sign of symptoms and continued for up to 7-10 days; continuous use beyond about 8 weeks is not recommended. Educational reference only, not a prescription.
References
Drug Class Interactions
Pairings
Garlic and ginger both reduce blood clotting/platelet stickiness, so taking them together may add up and raise the risk of bruising or bleeding — use caution, especially before surgery or alongside blood-thinning drugs.[30, 31]
Garlic and ginseng both reduce blood clotting/platelet stickiness, so taking them together may add up and raise the risk of bruising or bleeding — use caution, especially before surgery or alongside blood-thinning drugs.[30]
Garlic and feverfew both reduce blood clotting/platelet stickiness, so taking them together may add up and raise the risk of bruising or bleeding — use caution, especially before surgery or alongside blood-thinning drugs.[30, 32]
Garlic and black seed (Nigella sativa) can each mildly lower blood pressure, so taking them together — especially alongside blood-pressure medicines — may add up and lower blood pressure more than expected. Monitor your blood pressure.[29, 33]
Not documented
Lookalikes Review
Dangerous Lookalikes
Not documented
References & Sources
- El-Saber Batiha, G. and Magdy Beshbishy, A. and G Wasef, L. and Elewa, Y.H.A. and A Al-Sagan, A. and Abd El-Hack, M.E. and Taha, A.E. and M Abd-Elhakim, Y. and Prasad Devkota, H (2020) 'Chemical Constituents and Pharmacological Activities of Garlic (Allium sativum L.): A Review', Nutrients, 12(3), pp. 872. doi:10.3390/nu12030872 Meta-analysis / review
https://doi.org/10.3390/nu12030872 - Shang, A. and Cao, S.Y. and Xu, X.Y. and Gan, R.Y. and Tang, G.Y. and Corke, H. and Mavumengwana, V. and Li, H.B (2019) 'Bioactive Compounds and Biological Functions of Garlic (Allium sativum L.)', Foods, 8(7), pp. 246. doi:10.3390/foods8070246 Meta-analysis / review
https://doi.org/10.3390/foods8070246 - Mejia Delgado, E.M. and Quiroz-Aldave, J.E. and Durand-Vasquez, M.D.C. and Aldave-Pita, L.N. and Fuentes-Mendoza, J.M. and Concepcion-Urteaga, L.A. and Paz-Ibarra, J. and Concepcion-Zavaleta, M.J (2025) 'Immunomodulatory effect of Allium sativum in type 2 diabetes mellitus', World Journal of Experimental Medicine, 15(2), pp. 103481. doi:10.5493/wjem.v15.i2.103481 Meta-analysis / review
https://doi.org/10.5493/wjem.v15.i2.103481 - Majewski, M (2014) 'Allium sativum: facts and myths regarding human health', Roczniki Panstwowego Zakladu Higieny, 65(1), pp. 1-8. Meta-analysis / review
https://scholar.google.com/scholar?q=Allium%20sativum%3A%20facts%20and%20myths%20regarding%20human%20health - Mardi, P. and Kargar, R. and Fazeli, R. and Qorbani, M (2023) 'Allium sativum: A potential natural compound for NAFLD prevention and treatment', Frontiers in Nutrition, 10, pp. 1059106. doi:10.3389/fnut.2023.1059106 Meta-analysis / review
https://doi.org/10.3389/fnut.2023.1059106 - Sleiman, C., Daou, R.M., Al Hazzouri, A., Hamdan, Z., Ghadieh, H.E., Harbieh, B. and Romani, M (2024) 'Garlic and Hypertension: Efficacy, Mechanism of Action, and Clinical Implications', Nutrients, 16(17). doi:10.3390/nu16172895 Preclinical
https://doi.org/10.3390/nu16172895 - Serrano, J.C.E., Castro-Boque, E., Garcia-Carrasco, A., Moran-Valero, M.I., Gonzalez-Hedstrom, D., Bermudez-Lopez, M. and others (2023) 'Antihypertensive Effects of an Optimized Aged Garlic Extract in Subjects with Grade I Hypertension and Antihypertensive Drug Therapy: A Randomized, Triple-Blind Controlled Trial', Nutrients, 15(17). doi:10.3390/nu15173691 Randomized trial
https://doi.org/10.3390/nu15173691 - Choo, S., Chin, V.K., Wong, E.H., Madhavan, P., Tay, S.T., Yong, P.V.C. and Chong, P.P (2020) 'Review: antimicrobial properties of allicin used alone or in combination with other medications', Folia Microbiologica, 65(3), pp. 451--465. doi:10.1007/s12223-020-00786-5 Preclinical
https://doi.org/10.1007/s12223-020-00786-5 - Mikaili, P., Maadirad, S., Moloudizargari, M., Aghajanshakeri, S. and Sarahroodi, S (2013) 'Therapeutic uses and pharmacological properties of garlic, shallot, and their biologically active compounds', 16(10), pp. 1031--1048. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC3874089/ Traditional / reference
https://pmc.ncbi.nlm.nih.gov/articles/PMC3874089/ - Josling, P (2001) 'Preventing the common cold with a garlic supplement: a double-blind, placebo-controlled survey', 18(4), pp. 189--193. doi:10.1007/BF02850113 Randomized trial
https://doi.org/10.1007/BF02850113 - World Health Organization (1999) 'Bulbus Allii Sativi'. Available at: https://iris.who.int/items/6418d8af-5200-4e6b-9bf5-004f3aa62a37 Traditional / reference
https://iris.who.int/items/6418d8af-5200-4e6b-9bf5-004f3aa62a37 - European Medicines Agency (HMPC) (2017) 'European Union herbal monograph on Allium sativum L., bulbus'. Available at: https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-allium-sativum-l-bulbus_en.pdf Traditional / reference
https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-allium-sativum-l-bulbus_en.pdf - National Center for Complementary and Integrative Health (2021) 'Garlic'. Available at: https://www.nccih.nih.gov/health/garlic Traditional / reference
https://www.nccih.nih.gov/health/garlic - Ried, K (2016) 'Garlic lowers blood pressure in hypertensive individuals, regulates serum cholesterol, and stimulates immunity: an updated meta-analysis and review', 146(2), pp. 389S--396S. doi:10.3945/jn.114.202192 Meta-analysis / review
https://doi.org/10.3945/jn.114.202192 - Royal Botanic Gardens, Kew (n.d.) 'Allium sativum L'. Available at: https://powo.science.kew.org/taxon/urn:lsid:http://ipni.org:names:530118-1 Traditional / reference
https://powo.science.kew.org/taxon/urn:lsid:http://ipni.org:names:530118-1 - World Cancer Research Fund/American Institute for Cancer Research (2018) 'Diet, Nutrition, Physical Activity and Cancer: a Global Perspective (Continuous Update Project Expert Report)'. Available at: https://www.wcrf.org/dietandcancer Traditional / reference
https://www.wcrf.org/dietandcancer - Imaizumi, V.M., Laurindo, L.F., Manzan, B., Guiguer, E.L., Oshiiwa, M., Otoboni, A.M.M.B. and others (2022) 'Garlic: A systematic review of the effects on cardiovascular diseases', Critical Reviews in Food Science and Nutrition, 63(24), pp. 6797--6819. doi:10.1080/10408398.2022.2043821 Meta-analysis / review
https://doi.org/10.1080/10408398.2022.2043821 - Li, W.-Q. and Zhang, J.-Y. and Ma, J.-L. and Li, Z.-X. and Zhang, L. and Zhang, Y. and Guo, Y. and Zhou, T. and Li, J.-Y. and Shen, L. and Liu, W.-D. and Han, Z.-X. and Blot, W.J. and Gail, M.H. and Pan, K.-F. and You, W.-C (2019) 'Effects of Helicobacter pylori treatment and vitamin and garlic supplementation on gastric cancer incidence and mortality: follow-up of a randomized intervention trial', BMJ, 366, pp. l5016. doi:10.1136/bmj.l5016 Randomized trial
https://doi.org/10.1136/bmj.l5016 - Hassan, H.T (2004) 'Ajoene (natural garlic compound): a new anti-leukaemia agent for AML therapy', Leukemia Research, 28(7), pp. 667-671. doi:10.1016/j.leukres.2003.10.008 Preclinical
https://doi.org/10.1016/j.leukres.2003.10.008 - Agbana, Y.L. and Ni, Y. and Zhou, M. and Zhang, Q. and Kassegne, K. and Karou, S.D. and Kuang, Y. and Zhu, Y (2019) 'Garlic-derived bioactive compound S-allylcysteine inhibits cancer progression through diverse molecular mechanisms', Nutrition Research, 73, pp. 1-14. doi:10.1016/j.nutres.2019.11.002 Preclinical
https://doi.org/10.1016/j.nutres.2019.11.002 - Puccinelli, M.T. and Stan, S.D (2017) 'Dietary Bioactive Diallyl Trisulfide in Cancer Prevention and Treatment', International Journal of Molecular Sciences, 18(8), pp. 1645. doi:10.3390/ijms18081645 Preclinical
https://doi.org/10.3390/ijms18081645 - Borlinghaus, J. and Albrecht, F. and Gruhlke, M.C.H. and Nwachukwu, I.D. and Slusarenko, A.J (2014) 'Allicin: chemistry and biological properties', Molecules, 19(8), pp. 12591-12618. doi:10.3390/molecules190812591 Preclinical
https://doi.org/10.3390/molecules190812591 - Reiter, J., Levina, N., van der Linden, M., Gruhlke, M., Martin, C. and Slusarenko, A.J (2017) 'Diallylthiosulfinate (Allicin), a Volatile Antimicrobial from Garlic (Allium sativum), Kills Human Lung Pathogenic Bacteria, Including MDR Strains, as a Vapor', Molecules, 22(10). doi:10.3390/molecules22101711 Preclinical
https://doi.org/10.3390/molecules22101711 - Ried, K (2016) 'Garlic Lowers Blood Pressure in Hypertensive Individuals, Regulates Serum Cholesterol, and Stimulates Immunity: An Updated Meta-analysis and Review', Journal of Nutrition, 146(2), pp. 389S--396S. doi:10.3945/jn.114.202192 Meta-analysis / review
https://doi.org/10.3945/jn.114.202192 - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Piscitelli, S.C., Burstein, A.H., Welden, N., Gallicano, K.D. and Falloon, J (2002) 'The effect of garlic supplements on the pharmacokinetics of saquinavir', Clinical Infectious Diseases, 34(2), pp. 234-238. doi:10.1086/324351 Clinical study
https://doi.org/10.1086/324351 - Izzo, A.A. and Ernst, E (2009) 'Interactions between herbal medicines and prescribed drugs: an updated systematic review', Drugs, 69(13), pp. 1777-1798. doi:10.2165/11317010-000000000-00000 Meta-analysis / review
https://doi.org/10.2165/11317010-000000000-00000 - Shabani, E., Sayemiri, K. and Mohammadpour, M (2019) 'The effect of garlic on lipid profile and glucose parameters in diabetic patients: a systematic review and meta-analysis', Primary Care Diabetes, 13(1), pp. 28-42. doi:10.1016/j.pcd.2018.07.007 Meta-analysis / review
https://doi.org/10.1016/j.pcd.2018.07.007 - Ried, K (2016) 'Garlic Lowers Blood Pressure in Hypertensive Individuals, Regulates Serum Cholesterol, and Stimulates Immunity: An Updated Meta-analysis and Review', The Journal of Nutrition, 146(2), pp. 389S-396S. doi:10.3945/jn.114.202192 Meta-analysis / review
https://doi.org/10.3945/jn.114.202192 - Ang-Lee, M.K., Moss, J. and Yuan, C.S (2001) 'Herbal medicines and perioperative care', JAMA, 286(2), pp. 208-216. doi:10.1001/jama.286.2.208 Meta-analysis / review
https://doi.org/10.1001/jama.286.2.208 - Jiang, X., Williams, K.M., Liauw, W.S., Ammit, A.J., Roufogalis, B.D., Duke, C.C., Day, R.O. and McLachlan, A.J (2005) 'Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects', British Journal of Clinical Pharmacology, 59(4), pp. 425-432. doi:10.1111/j.1365-2125.2005.02322.x Randomized trial
https://doi.org/10.1111/j.1365-2125.2005.02322.x - Groenewegen, W.A. and Heptinstall, S (1990) 'A comparison of the effects of an extract of feverfew and parthenolide, a component of feverfew, on human platelet activity in-vitro', Journal of Pharmacy and Pharmacology, 42(8), pp. 553-557. doi:10.1111/j.2042-7158.1990.tb07057.x Preclinical
https://doi.org/10.1111/j.2042-7158.1990.tb07057.x - Sahebkar, A., Soranna, D., Liu, X., Thomopoulos, C., Simental-Mendia, L.E., Derosa, G., Maffioli, P. and Parati, G (2016) 'A systematic review and meta-analysis of randomized controlled trials investigating the effects of supplementation with Nigella sativa (black seed) on blood pressure', Journal of Hypertension, 34(11), pp. 2127-2135. doi:10.1097/HJH.0000000000001049 Meta-analysis / review
https://doi.org/10.1097/HJH.0000000000001049 - Galland-Decker, C. and Charmoy, A. and Jolliet, P. and Spertini, O. and Hugli, O. and Pantet, O (2015) 'Progressive organ failure after ingestion of wild garlic juice', The Journal of Emergency Medicine, 50(1), pp. 55-60. doi:10.1016/j.jemermed.2015.06.034 Clinical study
https://doi.org/10.1016/j.jemermed.2015.06.034 - Kupper, J. and Reichert, C (2009) 'Intoxications with plants', Therapeutische Umschau, 66(5), pp. 343-8. doi:10.1024/0040-5930.66.5.343 Clinical study
https://doi.org/10.1024/0040-5930.66.5.343 - Gabrscek, L. and Lesnicar, G. and Krivec, B. and Voga, G. and Sibanc, B. and Blatnik, J. and Jagodic, B (2004) 'Accidental poisoning with autumn crocus', Journal of Toxicology. Clinical Toxicology, 42(1), pp. 85-8. doi:10.1081/clt-120028750 Clinical study
https://doi.org/10.1081/clt-120028750 - German Federal Institute for Risk Assessment (BfR) (2023) 'Wild garlic: beware of mix-ups'. Available at: https://www.bfr.bund.de/en/press-release/baerlauch-vorsicht-vor-verwechslungen/ Traditional / reference
https://www.bfr.bund.de/en/press-release/baerlauch-vorsicht-vor-verwechslungen/ - Trebach, J. and Calleo, V. and Akbar, S. and Langston, J. and Filigenzi, M. and Hoffman, R.S (2022) 'Detectable digoxin concentrations in 3 patients with ramps misadventure', Wilderness and Environmental Medicine, 33(3), pp. 340-343. doi:10.1016/j.wem.2022.04.008 Clinical study
https://doi.org/10.1016/j.wem.2022.04.008 - Fink, S.L. and Robey, T.E. and Tarabar, A.F. and Hodsdon, M.E (2014) 'Rapid detection of convallatoxin using five digoxin immunoassays', Clinical Toxicology (Philadelphia, Pa.), 52(7), pp. 659-63. doi:10.3109/15563650.2014.932366 Preclinical
https://doi.org/10.3109/15563650.2014.932366 - Wild Food UK (2020) 'Wild garlic impostors'. Available at: https://www.wildfooduk.com/articles/identifying-mushrooms-and-plants/wild-garlic-impostors/ Traditional / reference
https://www.wildfooduk.com/articles/identifying-mushrooms-and-plants/wild-garlic-impostors/
- Karsch-Völk, M., Barrett, B., Kiefer, D., Bauer, R. et al (2014) 'Echinacea for preventing and treating the common cold', Cochrane Database of Systematic Reviews, 2(2), pp. CD000530. doi:10.1002/14651858.CD000530.pub3 Meta-analysis / review
https://doi.org/10.1002/14651858.CD000530.pub3 - Kamin, W., Seifert, G., Zwiauer, K., Bonhoeffer, J. et al (2025) 'Phytotherapy for acute respiratory tract infections in children: a systematically conducted, comprehensive review', Frontiers in Pediatrics, 13, pp. 1423250. doi:10.3389/fped.2025.1423250 Meta-analysis / review
https://doi.org/10.3389/fped.2025.1423250 - Fashner, J., Ericson, K. and Werner, S (2012) 'Treatment of the common cold in children and adults', American Family Physician, 86(2), pp. 153-159. Available at: https://pubmed.ncbi.nlm.nih.gov/22962927/ Traditional / reference
https://pubmed.ncbi.nlm.nih.gov/22962927/ - Manayi, A., Vazirian, M. and Saeidnia, S (2015) 'Echinacea purpurea: Pharmacology, phytochemistry and analysis methods', Pharmacognosy Reviews, 9(17), pp. 63-72. doi:10.4103/0973-7847.156353 Meta-analysis / review
https://doi.org/10.4103/0973-7847.156353 - Burlou-Nagy, C., Banica, F., Jurca, T., Vicas, L.G., Marian, E., Muresan, M.E., Bacskay, I., Kiss, R., Feher, P. and Pallag, A (2022) 'Echinacea purpurea (L.) Moench: Biological and Pharmacological Properties. A Review', Plants, 11(9), pp. 1244. doi:10.3390/plants11091244 Meta-analysis / review
https://doi.org/10.3390/plants11091244 - Hall, H., Fahlman, M.M. and Engels, H.J (2007) 'Echinacea purpurea and mucosal immunity', International Journal of Sports Medicine, 28(9), pp. 792-797. doi:10.1055/s-2007-964895 Randomized trial
https://doi.org/10.1055/s-2007-964895 - Ross, S.M (2016) 'Echinacea purpurea: A Proprietary Extract of Echinacea purpurea Is Shown to be Safe and Effective in the Prevention of the Common Cold', Holistic Nursing Practice, 30(1), pp. 54-57. doi:10.1097/HNP.0000000000000130 Meta-analysis / review
https://doi.org/10.1097/HNP.0000000000000130 - Hudson, J.B (2011) 'Applications of the phytomedicine Echinacea purpurea (Purple Coneflower) in infectious diseases', Journal of Biomedicine & Biotechnology, 2012, pp. 769896. doi:10.1155/2012/769896 Meta-analysis / review
https://doi.org/10.1155/2012/769896 - Mishima, S., Saito, K., Maruyama, H., Inoue, M., Yamashita, T., Ishida, T. and Gu, Y (2004) 'Antioxidant and immuno-enhancing effects of Echinacea purpurea', Biological & Pharmaceutical Bulletin, 27(7), pp. 1004-1009. doi:10.1248/bpb.27.1004 Preclinical
https://doi.org/10.1248/bpb.27.1004 - Saunders, P.R., Smith, F. and Schusky, R.W (2007) 'Echinacea purpurea L. in children: safety, tolerability, compliance, and clinical effectiveness in upper respiratory tract infections', Canadian Journal of Physiology and Pharmacology, 85(11), pp. 1195-1199. doi:10.1139/Y07-103 Clinical study
https://doi.org/10.1139/Y07-103 - Micheli, L., Maggini, V., Ciampi, C., Gallo, E., Bogani, P., Fani, R., Pistelli, L., Ghelardini, C., Di Cesare Mannelli, L., De Leo, M. and Firenzuoli, F (2022) 'Echinacea purpurea against neuropathic pain: Alkamides versus polyphenols efficacy', Phytotherapy Research, 37(5), pp. 1911-1923. doi:10.1002/ptr.7709 Preclinical
https://doi.org/10.1002/ptr.7709 - Gholami, M., Amri, J., Pazhoohan, S. and Sadegh, M (2021) 'Anticonvulsive and anti-epileptogenesis effects of Echinacea purpurea root extract, an involvement of CB2 receptor', Journal of Complementary & Integrative Medicine, 19(4), pp. 879-886. doi:10.1515/jcim-2020-0219 Preclinical
https://doi.org/10.1515/jcim-2020-0219 - Awortwe, C., Bruckmueller, H., Kaehler, M. and Cascorbi, I (2021) 'Interaction of Phytocompounds of Echinacea purpurea with ABCB1 and ABCG2 Efflux Transporters', Molecular Pharmaceutics, 18(4), pp. 1622-1633. doi:10.1021/acs.molpharmaceut.0c01075 Preclinical
https://doi.org/10.1021/acs.molpharmaceut.0c01075 - Perry, N.B., van Klink, J.W., Burgess, E.J. and Parmenter, G.A (1997) 'Alkamide levels in Echinacea purpurea: a rapid analytical method revealing differences among roots, rhizomes, stems, leaves and flowers', Planta Medica, 63(1), pp. 58-62. doi:10.1055/s-2006-957605 Preclinical
https://doi.org/10.1055/s-2006-957605 - Linde, K., Barrett, B., Wölkart, K., Bauer, R. and Melchart, D (2006) 'Echinacea for preventing and treating the common cold'. Traditional / reference
https://scholar.google.com/scholar?q=Echinacea%20for%20preventing%20and%20treating%20the%20common%20cold - Sharma, M., Schoop, R., Suter, A. and Schoop, W (2010) 'The possibility of prophylactic treatment of streptococcal pharyngotonsillitis with a standardized Echinacea preparation', 29(8), pp. 1025--1035. Traditional / reference
https://scholar.google.com/scholar?q=The%20possibility%20of%20prophylactic%20treatment%20of%20streptococcal%20pharyngotonsillitis%20with%20a%20standardized%20Echinacea%20preparation - World Health Organization (1999) 'WHO Monographs on Selected Medicinal Plants'. Traditional / reference
https://scholar.google.com/scholar?q=WHO%20Monographs%20on%20Selected%20Medicinal%20Plants - Duke, J.A (2002) 'Handbook of Medicinal Herbs, Second Edition'. Traditional / reference
https://scholar.google.com/scholar?q=Handbook%20of%20Medicinal%20Herbs%2C%20Second%20Edition - Gorski, J.C., Huang, S.M., Pinto, A., Hamman, M.A., Hilligoss, J.K., Zaheer, N.A., Desai, M., Miller, M. and Hall, S.D (2004) 'The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo', Clinical Pharmacology and Therapeutics, 75(1), pp. 89-100. doi:10.1016/j.clpt.2003.09.013 Clinical study
https://doi.org/10.1016/j.clpt.2003.09.013
Generated automatically from the Omnia Sana plant database and its cited sources. For educational purposes only — not medical advice. Always consult a qualified practitioner before using medicinal plants.